SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rolando M. D’Angelillo, Pierfrancesco Franco, Berardino De Bari, Alba Fiorentino, Stefano Arcangeli, Filippo Alongi, Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era, Critical Reviews in Oncology/Hematology, 2015, 93, 2, 136

    CrossRef

  2. 2
    Yasuhiro Yamada, Koji Masui, Tsuyoshi Iwata, Yasuyuki Naitoh, Kei Yamada, Tsuneharu Miki, Koji Okihara, Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: Outcome and toxicity, Brachytherapy, 2015, 14, 2, 118

    CrossRef

  3. 3
    J. Nicholas Lukens, Mauricio Gamez, Kenneth Hu, Louis B. Harrison, Modern Brachytherapy, Seminars in Oncology, 2014, 41, 6, 831

    CrossRef

  4. 4
    G.C. Morton, P.J. Hoskin, Brachytherapy: Current Status and Future Strategies — Can High Dose Rate Replace Low Dose Rate and External Beam Radiotherapy?, Clinical Oncology, 2013, 25, 8, 474

    CrossRef

  5. 5
    Mark Shilkrut, P. William McLaughlin, Gregory S. Merrick, Jeffrey M. Vainshtein, Felix Y. Feng, Daniel A. Hamstra, Interval to Biochemical Failure Predicts Clinical Outcomes in Patients With High-Risk Prostate Cancer Treated by Combined-Modality Radiation Therapy, International Journal of Radiation Oncology*Biology*Physics, 2013, 86, 4, 721

    CrossRef

  6. 6
    Hira Lal Goel, Aejaz Sayeed, Michael Breen, Matthew J. Zarif, David S. Garlick, Irwin Leav, Roger J. Davis, Thomas J. FitzGerald, Andrea Morrione, Chung-Cheng Hsieh, Qin Liu, Adam P. Dicker, Dario C. Altieri, Lucia R. Languino, β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1, Journal of Cellular Physiology, 2013, 228, 7
  7. 7
    Christina Berndt, Jörg Zimmermann, Hohes Risiko: Androgene und Brachytherapie optimieren die Bestrahlung, Im Focus Onkologie, 2012, 15, 12, 33

    CrossRef